DMKJ
David M. Knott Jr’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-106,185
| Closed | -$254K | – | 101 |
|
|
2024
Q1 | $254K | Sell |
106,185
-420,127
| -80% | -$1M | 0.09% | 61 |
|
|
2023
Q4 | $1.75M | Sell |
526,312
-103,688
| -16% | -$345K | 0.67% | 24 |
|
|
2023
Q3 | $2.36M | Buy |
630,000
+384,990
| +157% | +$1.44M | 0.9% | 18 |
|
|
2023
Q2 | $1.05M | Buy |
+245,010
| New | +$1.05M | 0.42% | 41 |
|
|
2023
Q1 | – | Sell |
-128,517
| Closed | -$1.02M | – | 156 |
|
|
2022
Q4 | $1.02M | Sell |
128,517
-71,483
| -36% | -$566K | 0.38% | 44 |
|
|
2022
Q3 | $1.92M | Buy |
200,000
+13,866
| +7% | +$133K | 0.81% | 27 |
|
|
2022
Q2 | $1.35M | Buy |
186,134
+68,579
| +58% | +$497K | 0.57% | 43 |
|
|
2022
Q1 | $1.52M | Buy |
117,555
+15,000
| +15% | +$194K | 0.48% | 50 |
|
|
2021
Q4 | $1.64M | Buy |
+102,555
| New | +$1.64M | 0.56% | 44 |
|